Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Catalyst-Free Collagen Filament Crosslinking for Engineering Anisotropic and Mechanically Robust Tissue Scaffolds.

Kim J., Hwangbo H., Choi B., Yoon D., Kim G.

Animal Study, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Adv Sci (Weinh) (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
41250951
PMCID
PMC12903963
DOI
10.1002/advs.202514319
Citations
1

Abstract (original English)

Engineering mechanically resilient hydrogels from naturally derived proteins, such as collagen and gelatin, remains a key challenge in tissue regeneration, particularly when cell compatibility and structural integrity are simultaneously required. Here, a bioorthogonal crosslinking strategy using rhodamine and polyethylene glycol (PEG) is reported to fabricate dense, mechanically reinforced collagen hydrogels. PEG-mediated dehydration induces spontaneous peptide bond formation between rhodamine and collagen without the need for additional catalysts, yielding fibrous protein networks with enhanced stiffness. To enable anisotropic tissue engineering, this crosslinking method is integrated with wet-spinning to produce uniaxially aligned collagen filaments. These constructs exhibit high mechanical strength and support human adipose-derived stem cell (hASC) encapsulation. Mechanotransductive signaling, including cytoskeletal organization and myogenic gene expression, is effectively activated within the aligned filaments. The applicability of cell-laden filaments in a murine volumetric muscle loss model is demonstrated, which promoted in vitro differentiation and in vivo functional muscle regeneration. This strategy offers a scalable and cytocompatible platform for generating aligned protein-based scaffolds with tunable mechanical and biological properties, thereby expanding the toolk

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Tissue ScaffoldsTissue EngineeringCollagenAnimalsHumansMiceHydrogelsAnisotropyCross-Linking Reagents

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.